Off-the-shelf mesenchymal stem cells from human umbilical cord tissue can significantly improve symptoms in COVID-19 patients: An analysis of evidential relations

Coronavirus disease-2019 (COVID-19) has affected more than 200 countries worldwide. This disease has hugely affected healthcare systems as well as the economy to an extent never seen before. To date, COVID-19 infection has led to about 165000 deaths in 150 countries. At present, there is no specific...

Descripción completa

Detalles Bibliográficos
Autores principales: Pham, Phuc Van, Vu, Ngoc Bich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Opinion Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477657/
https://www.ncbi.nlm.nih.gov/pubmed/32952854
http://dx.doi.org/10.4252/wjsc.v12.i8.721
_version_ 1783579947160305664
author Pham, Phuc Van
Vu, Ngoc Bich
author_facet Pham, Phuc Van
Vu, Ngoc Bich
author_sort Pham, Phuc Van
collection PubMed
description Coronavirus disease-2019 (COVID-19) has affected more than 200 countries worldwide. This disease has hugely affected healthcare systems as well as the economy to an extent never seen before. To date, COVID-19 infection has led to about 165000 deaths in 150 countries. At present, there is no specific drug or efficient treatment for this disease. In this analysis based on evidential relationships of the biological characteristics of MSCs, especially umbilical cord (UC)-derived MSCs as well as the first clinical trial using MSCs for COVID-19 treatment, we discuss the use of UC-MSCs to improve the symptoms of COVID-19 in patients.
format Online
Article
Text
id pubmed-7477657
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-74776572020-09-18 Off-the-shelf mesenchymal stem cells from human umbilical cord tissue can significantly improve symptoms in COVID-19 patients: An analysis of evidential relations Pham, Phuc Van Vu, Ngoc Bich World J Stem Cells Opinion Review Coronavirus disease-2019 (COVID-19) has affected more than 200 countries worldwide. This disease has hugely affected healthcare systems as well as the economy to an extent never seen before. To date, COVID-19 infection has led to about 165000 deaths in 150 countries. At present, there is no specific drug or efficient treatment for this disease. In this analysis based on evidential relationships of the biological characteristics of MSCs, especially umbilical cord (UC)-derived MSCs as well as the first clinical trial using MSCs for COVID-19 treatment, we discuss the use of UC-MSCs to improve the symptoms of COVID-19 in patients. Baishideng Publishing Group Inc 2020-08-26 2020-08-26 /pmc/articles/PMC7477657/ /pubmed/32952854 http://dx.doi.org/10.4252/wjsc.v12.i8.721 Text en ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Opinion Review
Pham, Phuc Van
Vu, Ngoc Bich
Off-the-shelf mesenchymal stem cells from human umbilical cord tissue can significantly improve symptoms in COVID-19 patients: An analysis of evidential relations
title Off-the-shelf mesenchymal stem cells from human umbilical cord tissue can significantly improve symptoms in COVID-19 patients: An analysis of evidential relations
title_full Off-the-shelf mesenchymal stem cells from human umbilical cord tissue can significantly improve symptoms in COVID-19 patients: An analysis of evidential relations
title_fullStr Off-the-shelf mesenchymal stem cells from human umbilical cord tissue can significantly improve symptoms in COVID-19 patients: An analysis of evidential relations
title_full_unstemmed Off-the-shelf mesenchymal stem cells from human umbilical cord tissue can significantly improve symptoms in COVID-19 patients: An analysis of evidential relations
title_short Off-the-shelf mesenchymal stem cells from human umbilical cord tissue can significantly improve symptoms in COVID-19 patients: An analysis of evidential relations
title_sort off-the-shelf mesenchymal stem cells from human umbilical cord tissue can significantly improve symptoms in covid-19 patients: an analysis of evidential relations
topic Opinion Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477657/
https://www.ncbi.nlm.nih.gov/pubmed/32952854
http://dx.doi.org/10.4252/wjsc.v12.i8.721
work_keys_str_mv AT phamphucvan offtheshelfmesenchymalstemcellsfromhumanumbilicalcordtissuecansignificantlyimprovesymptomsincovid19patientsananalysisofevidentialrelations
AT vungocbich offtheshelfmesenchymalstemcellsfromhumanumbilicalcordtissuecansignificantlyimprovesymptomsincovid19patientsananalysisofevidentialrelations

Ejemplares similares